Stock UniverseDerived research view · source repositories remain read-only

Tarsus Pharmaceuticals, Inc. (TARS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
38.83
Global Rank
565
Market Cap
3.21B
Latest Close
59.28
RS Composite
-25.02% · G#2860

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-8.46%
3M
-19.08%
6M
-27.60%
1Y
38.99%
3Y
253.91%
5Y
77.91%
10Y
188.05%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 358.81K · 30-day average: 750.64K · Max drawdown over stored range: -77.67%

Research Snapshot

Relative Strength vs SPX

RS Composite-25.02%
20D RS-7.95%
60D RS-24.14%
120D RS-34.44%
Global RS Rank2860 · 14.75% percentile
Qualified+ RS Rank1107 · 12.00% percentile
Group ScopeQualified+
Primary RS Rank335 · 26.86% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank73 / 701
Primary Percentile89.73
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-06535.08Mn/a-50.81M-48.27M-1.13-87.14M17.27M-104.41M43Mn/a-9.50%-9.02%-16.29%-19.51%388.73M72.60M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.13-52.4x$12.544.7x$-2.45-24.2x$-2.04-29.0x

Shares Diluted: 43M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue057.02725.81617.447182.953451.36
Revenue Growth (YoY)3100%3100%-54.73%-32.418%948.622%146.708%
Gross Profit-18.82613.24-17.763-34.458116.741356.354
Operating Income-26.998-12.157-62.712-143.158-120.569-70.969
Free Cash Flow-21.5943.162-49.536-118.995-84.594-22.31
Free Cash Flow Per Share-3.4790.154-2.012-4.05-2.25-0.534
EPS (Diluted) GAAP-4.319222-0.672712-2.522004-4.624841-3.072873-1.589555
EPS Growth
EPS Non-GAAP
Gross Margin3100%23.217%-68.806%-197.501%63.809%78.951%
Operating Margin3100%-21.318%-242.919%-820.531%-65.902%-15.723%
Profit Margin3100%-24.246%-240.514%-778.89%-63.16%-14.715%
Free Cash Flow Margin3100%5.545%-191.881%-682.037%-46.238%-4.943%
Shares Outstanding (Diluted)6.207420.554124.619729.383337.604541.784
Shares Change (YoY)162.716%231.124%19.78%19.349%27.979%11.114%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06162.05Mn/a-6.12M-3.78%-6.97M-4.30%-0.1642.96M388.73M72.60Mprocessed
2025 Q42026-02-23151.67Mn/a-7.98M-5.26%-8.37M-5.52%-0.2042.76M417.27M72.44Mprocessed
2025 Q32025-11-04118.70Mn/a-14.53M-12.24%-12.59M-10.60%-0.3042.61M401.84M72.28Mprocessed
2025 Q22025-08-06102.66Mn/a-22.18M-21.61%-20.34M-19.81%-0.4842.36M381.14M72.13Mprocessed
2025 Q12025-05-0178.33Mn/a-26.28M-33.55%-25.12M-32.07%-0.6439.35M407.92M71.98Mprocessed
2024 Q42025-02-2566.41Mn/a-24.42M-36.77%-23.11M-34.80%-0.6038.56M291.38M71.84Mprocessed
2024 Q32024-11-1348.12Mn/a-25.16M-52.29%-23.42M-48.67%-0.6138.38M316.95M71.71Mprocessed
2024 Q22024-08-0840.81Mn/a-33.30M-81.60%-33.29M-81.57%-0.8837.82M323.58M71.58Mprocessed
2024 Q12024-05-0827.61Mn/a-37.68M-1.36%-35.73M-1.29%-1.0135.30M298.52M29.93Mprocessed
2023 Q42024-02-2713.08Mn/a-44.45M-3.40%-41.90M-3.20%-1.2633.34M227.44M29.82Mprocessed
2023 Q32023-11-091.87Mn/a-40.94M-21.88%-39.15M-20.92%-1.2830.62M246.88M29.71Mprocessed
2023 Q22023-08-1015.28Mn/a-32.82M-2.15%-31.42M-2.06%-1.1726.82M178.23M24.61Mprocessed
2023 Q12023-05-092.50Mn/a-24.95M-9.98%-23.42M-9.37%-0.8826.74M201.22M24.52Mprocessed
2022 Q42023-03-1710.00Mn/a-15.06M-1.51%-13.60M-1.36%-0.5126.71M217.03M19.43Mprocessed
2022 Q32022-11-091.24Mn/a-22.91M-18.47%-22.51M-18.15%-0.8426.66M226.57M19.36Mprocessed
2022 Q22022-08-1115.28Mn/a-5.22M-34.20%-5.74M-37.59%-0.2424.33M245.85M19.26Mprocessed
2022 Q12022-05-11539.00Kn/a-19.52M-36.22%-20.24M-37.55%-0.9820.71M175.30M19.18Mprocessed
2021 Q42022-03-14338.00Kn/a-14.45M-42.75%-14.85M-43.94%-0.9216.12M171.81Mn/aprocessed
2021 Q32021-11-101.24Mn/a-15.71M-12.67%-15.70M-12.66%-0.7620.64M183.80Mn/aprocessed
2021 Q22021-08-0522.02Mn/a7.28M33.07%6.34M28.82%0.2921.97M176.74Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.